| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $23.2M | $21.2M | $15.5M |
| YoY Revenue Growth % | +9.6% | +36.9% | — |
| Gross Profit | $3.1M | $2.5M | — |
| Gross Margin % | 13.3% | 11.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$4.1M | -$1.9M | $819.0K |
| Operating Margin % | -17.5% | -9.2% | 5.3% |
| Net Income (GAAP) | -$5.5M | -$812.8K | $969.6K |
| EBITDA (Normalized) | -$3.7M | -$1.7M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$1.7M | -$2.9M | -$1.4M |
| Capital Expenditures (CapEx) | $427.1K | $325.3K | — |
| Free Cash Flow (FCF) | -$2.1M | -$3.3M | -$1.4M |
| FCF Margin % | -9.2% | -15.4% | -9.2% |
| Return on Invested Capital (ROIC %) | -45.0% | -18.8% | — |
| Cash & Short-Term Equivalents | $908.3K | $1.4M | — |
| Total Debt (Short + Long Term) | $95.4K | $236.5K | — |
| Total Stockholders' Equity | $7.0M | $9.3M | — |